Skd Pharma Products Private Limited, a active private limited company, was established on 11 August 2015 in Hyderabad, Telangana, India. Engaging in pharmaceutical packaging solutions within the manufacturing sector, it holds CIN: U25203TG2015PTC100184. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.57 Cr.
It upholds a compliant status. Employing 13 professional, Its leadership includes Konduru Suresh Kumar Raju (Director), Vijayalakshmi Konduru (Director), Konduru Ramesh Raju (Director). Past directors included Sarada Burri, Geetha Bala Chenagani. It holds ₹8.14 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 92, Apparel Export Park Gundla Pochampally, Hyderabad, Telangana, 500014.
U25203TG2015PTC100184
100184
11 August 2015
₹3.00 Cr
₹1.57 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Skd Pharma Products Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Konduru Suresh Kumar Raju | Director | 12 May 2020 | Current |
| Vijayalakshmi Konduru | Director | 11 Aug 2015 | Current |
| Konduru Ramesh Raju | Director | 03 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Feb 2019 | Past |
| Pramod Abcsdd | Director | 12 May 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Skd Pharma Products Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.51% increase. The company also saw a substantial improvement in profitability, with a 32.22% increase in profit. The company's net worth Soared by an impressive increase of 73.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Skd Pharma Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹81,354,200.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jul 2025 | Canara Bank | ₹5.53 Cr | Open |
| 23 Nov 2023 | Canara Bank | ₹1.40 M | Open |
| 30 Aug 2023 | Canara Bank | ₹2.00 Cr | Open |
| 09 Dec 2020 | Canara Bank | ₹3.50 M | Open |
| 22 Jul 2019 | Others | ₹1.15 M | Open |
Explore comprehensive loan charge details -
Skd Pharma Products has a workforce of 13 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Skd Pharma Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skd Pharma Products's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Skd Pharma Products Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
A charge with Canara Bank amounted to Rs. 5.53 Cr with Charge ID 101124670 was registered on 16 Jul 2025. was recorded as a recent event.
The activity A charge with Canara Bank of Rs. 2.00 Cr registered on 30 Aug 2023 with Charge ID 100791974 was modified on 16 Jul 2025. was completed.
The activity Konduru Ramesh Raju was appointed as a Director was appointed as a Director on 03 Jul 2025 & has been associated with this company since 5 months 21 days . was completed.
Progress on Skd Pharma Products Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
The activity A charge with Canara Bank amounted to Rs. 0.14 Cr with Charge ID 100836996 was registered on 23 Nov 2023. was completed.
The CIN of Skd Pharma Products Private Limited is U25203TG2015PTC100184.
Skd Pharma Products Private Limited is headquartered at Plot No. 92, Apparel Export Park Gundla Pochampally, Hyderabad, Telangana, 500014.
Skd Pharma Products Private Limited was incorporated on 11 August 2015.
The current directors of Skd Pharma Products Private Limited are
The primary industry of Skd Pharma Products Private Limited is Manufacturing.
Skd Pharma Products Private Limited is unlisted.
The authorized capital of Skd Pharma Products Private Limited is ₹3.00 Cr, and the paid-up capital is ₹1.57 Cr.
The compliance status of Skd Pharma Products Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX